TrovaGene, Inc.

1.19

0.0000

Volume:- -

Turnover:- -

Market Cap:13.10M

PE:-0.42

High:1.19

Open:1.19

Low:1.19

Close:1.19

Loading ...

Overview Company News Filings

Concept

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance

PR Newswire

·

20 Oct 2020

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TROV"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TROV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","market":"US","secType":"STK","nameCN":"TrovaGene, Inc.","latestPrice":1.19,"timestamp":1588881600000,"preClose":1.19,"halted":8,"volume":0,"delay":0,"floatShares":9635604,"shares":11011100,"eps":-2.8,"marketStatus":"Pre-Mkt","change":0,"latestTime":"05-12 06:50:00 EDT","open":1.19,"high":1.19,"low":1.19,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.8,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1747056600000},"marketStatusCode":1,"symbolChange":{"newSymbol":"CRDF","executeDate":"2020-05-08"},"adr":0,"adrRate":0,"listingDate":1059624000000,"exchange":"NASDAQ","adjPreClose":1.19,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TROV\",,,,,undefined,":{"symbol":"TROV","floatShares":9635604,"roa":"-76.48%","roe":"-188.72%","lyrEps":-2.796607,"shares":11011100,"dividePrice":0,"high":1.19,"amplitude":0,"preClose":1.19,"low":1.19,"week52Low":0.701,"pbRate":"1.79","week52High":3.46,"institutionHeld":0,"latestPrice":1.19,"eps":-2.8,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.8,"open":1.19},"@#url:\"https://hq.skytigris.cn/market/plate/belongs/TROV\",params:#limit:6,delay:false,,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TROV\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2077534973","title":"Cardiff Oncology Presents Positive Efficacy and Biomarker Data from mCRPC Trial Demonstrating Ability of Onvansertib to Overcome Zytiga® Resistance","url":"https://stock-news.laohu8.com/highlight/detail?id=2077534973","media":"PR Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2077534973?lang=en_us&edition=fundamental","pubTime":"2020-10-20 20:30","pubTimestamp":1603197000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/_cGEgMngafg1N90T2BYc8Q--~B/aD04MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/nFfxekdkc8Af_XcBJxouPA--~B/aD04MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/de9bcad10127c56c5b1f2d3c5fb177c7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/_cGEgMngafg1N90T2BYc8Q--~B/aD04MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/nFfxekdkc8Af_XcBJxouPA--~B/aD04MTt3PTQwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/prnewswire.com/de9bcad10127c56c5b1f2d3c5fb177c7"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/cardiff-oncology-presents-positive-efficacy-123000768.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/cardiff-oncology-presents-positive-efficacy-123000768.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TROV","CRDF"],"gpt_icon":0}],"pageSize":4,"totalPage":1,"pageCount":1,"totalSize":1,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TROV\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-08","symbol":"TROV","oldSymbol":"TROV","newSymbol":"CRDF","exchange":"NASDAQ","type":"symbolChange","dateTimestamp":1588910400000},{"market":"US","date":"2020-05-05","symbol":"TROV","fiscalQuarterEnding":"2020/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1588651200000,"reportTimeType":"","actualEps":-1.02},{"market":"US","date":"2020-02-27","symbol":"TROV","fiscalQuarterEnding":"2019/12","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1582779600000,"reportTimeType":"","actualEps":-0.51},{"market":"US","date":"2019-11-07","symbol":"TROV","fiscalQuarterEnding":"2019/09","expectedEps":-0.84,"name":null,"time":"","type":"earning","dateTimestamp":1573102800000,"reportTimeType":"","actualEps":-0.71},{"market":"US","date":"2019-08-08","symbol":"TROV","fiscalQuarterEnding":"2019/06","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1565236800000,"reportTimeType":"","actualEps":-0.79}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TROV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TROV\",market:\"US\",delay:false,,,undefined,":{}}}